Conference · Paris, France
International Symposium on Targeted Anticancer Therapies (TAT) 2013
Health
Key numbers
- Floor space
- NULLin 2014, organiser's figure
- Editions on record
- 4first in 2010
About International Symposium on Targeted Anticancer Therapies (TAT)
TAT 2013 in Paris, will be the next meeting in the unique series "International Congress on Targeted Anticancer Therapies" (TAT), which is devoted to the most promising new molecularly-targeted cancer therapeutics. TAT meetings are leading oncology phase 1 meetings in Europe and a must-attend for clinical investigators, research scientists and drug development professionals in pharma, biotech and CROs:
-Focus on promising new agents and molecular targets that are - or soon will be - in phase 1 clinical study
-Clinical and translational research discussed extensively
-Educational introductions of target biology help "newcomers" understand the science behind new targets
-Open, academic atmosphere and highly interactive setting
-Completely plenary program - no parallel sessions
-Excellent opportunities for young investigators to present for the first time in their carreer in a comfortable and overseeable setting
-Many of the world's leading phase 1 groups represented on TAT faculty
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 4–6 Mar 2014 | Georgetown University Hotel & Conference Center Washington, District of Columbia | — | — |
| 2013 | 4–6 Mar 2013 | Paris Marriott Rive Gauche Hotel & Conference Center Paris, France | — | — |
| 2012 | 8–10 Mar 2012 | Amsterdam RAI International Exhibition Center Amsterdam, Netherlands | — | — |
| 2010 | 4–6 Mar 2010 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.